Rat Model Market Size, Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Japan, China, Australia, India, Brazil, Mexico, Argentina, Saudi Arabia, South Africa, UAE), Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025
Report ID: GMI4165
Rat Model Market size is projected to experience significant growth from 2019 to 2025.
The rat model market is estimated to grow at a robust rate in the near future. The growth of the market is attributed to several advantages offered by the rat model. The rat model is an ideal option for various labs owing to their large size and physiological resemblance to humans. These attributes make sampling, handling and performing procedures on the rat easy. Hence, several advantages of the rat model will augment the business growth in the near future.
Recent technological advancements will have a positive impact on the growth of rat model market in the forthcoming years. Due to recent advances in gene editing and gene targeting it has become possible to specifically modify the rat genome to produce knockouts. This has further helped in understanding the human disease through the development of powerful and customized CRISPR rat models. Also, better rat models have decreased drug failure in clinical trials, resulting in decreasing development costs and time to market. Hence, aforementioned technological developments will spur the rat model market growth in the future.
However, certain disadvantages of the rat model will hamper the market growth in the upcoming years. Disadvantages such as accelerating intrinsic healing, high density of cells in cartilage causing efficient healing and thickness defects. Hence, certain physiological factors will impede the industry growth.
Outbred rat model type market is estimated to hold significant amount of market share owing to presence of certain genetic variations among the original strain which is evident for minimum four generations. These models allow an in-depth analysis and research along with further assistance in predicting certain variations in reactions for the same drug by individual animals. Thus, above mentioned factors will increase the demand for outbred rat model, fueling the business growth.
Breeding services segment is estimated to hold significant market share. High need of rats for further research and clinical trials will require extensive breeding of the rats. The company, Charles River Laboratories International, Inc. provides its clients with option of only breeding. Increase in number of service providers offering breeding service will boost the market growth.
CRISPR technology market is estimated to show robust growth over the forecast period. The growth is attributed to growing demand for genetically modified and conditioned animals. This technology is used to modify DNA in the rat to study specific disease phenotypes and develop new treatments. The CRISPR technology is using higher application within the rat-based research activity to assist several users. Hence, growing demand of CRISPR technology among the end-users will augment the market growth.
Use of rat models in neurology will have significant contribution in the market share. Increase in incidence of diseases such as stroke, Alzheimer’s and Parkinson’s disease will spur the need for new drug development and treatment for neurological disorders. As per the National Institutes of Health (NIH), these neurological disorders cause heavy economic burden in North America and Europe. Growing production of drugs for the treatment of these neurological diseases will enhance the business growth.
Healthcare companies as an end-use segment will witness significant market growth in the near future. Increase in demand and need for medication along with recent technological advancements in development of novel drugs has resulted in healthcare companies investing more in R&D expenditure. Hence, aforementioned factors will boost the market growth.
U.S. rat model market is estimated to substantial amount of market share owing to presence of several major healthcare companies. Also, increase in number of people suffering from chronic conditions and growing healthcare economic burden will boost the research activities, augmenting the industry growth.
Some of the major industry players are Charles River Laboratories International, Inc., Taconic Biosciences, Envigo, Laboratory Corporation of America Holdings, Janvier Labs among others. These market players focus on enhancing their market presence by implementing several strategies such as new product developments, increase in R&D expenditure, mergers, acquisitions, partnerships, and collaborations.
Rat Model Market, By Type, 2014-2025 (USD Million)
- Outbred Rats
- Inbred Rats
- Genetically Engineered Rats (Knockout)
- Congenic Rats (Hybrid)
- Surgically Modified Rats
- Immunodeficient Rats
Rat Model Market, By Service 2014-2025 (USD Million)
- Model In-Licensing
- Genetic Testing
Rat Model Market, By Technology, 2014-2025 (USD Million)
- Embryonic Stem Cell Injection
- Nuclear Transfer
Rat Model Market, By Therapeutic Area, 2014-2025 (USD Million)
- Immunology and Inflammation
Rat Model Market, By End-use, 2014-2025 (USD Million)
- Healthcare Companies
- Academic and Research Institutes
- Contract Research Organizations (CRO)
The above information is provided for the following regions and countries:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
- South Africa
- Saudi Arabia
- Charles River Laboratories International, Inc.
- Taconic Biosciences
- Laboratory Corporation of America Holdings
- Janvier Labs
- Genoway S.A.
- Transposagen Biopharmaceuticals
- Horizon Discovery Group
What Information does this report contain?
Customize this Report
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability
Why Global Market Insights, Inc.?
- GMI is unparalleled when to comes to the quality of research and information provided to clients. Our unique methodology is designed to ensure a minimum of 90% accuracy to give our clients excellent value on their investment.
Over 200 experts are available across various time-zones, ready to serve clients for their research needs. Our industry experts help clients to design reports customized to their needs.